https://www.optimumcomms.com/wp-content/uploads/2023/06/Vicore_Pharma_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-17 11:07:272023-06-09 14:56:41Vicore to host webcast with updated AIR trial results after presentation at the ATS congress
https://www.optimumcomms.com/wp-content/uploads/2023/06/Vicore_Pharma_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-17 11:07:272023-06-09 14:56:41Vicore to host webcast with updated AIR trial results after presentation at the ATS congress
Peer-Reviewed Translational Research Paves The Way For First-In-Class Autotaxin Inhibitor IOA-289 In Cancer
Amsterdam, The Netherlands and Geneva, Switzerland, 16 May 2023 -…

Acesion Pharma Announces Positive Pre-Clinical Data for AP31969
Copenhagen, Denmark – Acesion Pharma (“Acesion” or “the…

Vicore strengthens its Board of Directors
Stockholm, May 12, 2023 – Vicore Pharma Holding AB (STO: VICO)…

BII appointed by the Danish government to run international deep tech start-up accelerator
BioInnovation Institute (BII), an international non-profit foundation…

UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer
UCB’s expertise in macrocyclic peptide discovery, using…

STIMULAN® now available in South Africa to treat bacterial infection
Novus Healthcare will exclusively distribute STIMULAN® and genex…

Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
NDA submission on schedule for Q2 2023
12 abstracts and one…

Neuraxpharm rebrands Laboratorios Lesvi as Neuraxpharm Pharmaceuticals S.L.
Laboratorios Lesvi is Neuraxpharm’s manufacturing facility…

BII-startups pursue US expansion opportunities through TMC BioBridge
Texas Medical Center (TMC) and the BioInnovation Institute (BII)…

iOnctura Expands Pipeline And Receives Development Grant From Health Holland And KWF
Licensing deal gives iOnctura exclusive global development…

Vicore initiates clinical proof-of-concept study of endothelial dysfunction
Stockholm, May 3, 2023 – Vicore Pharma Holding AB (STO:…

Verona Pharma to Present Expanded Analyses of Positive Phase 3 ENHANCE Studies in COPD in Multiple Presentations at ATS 2023
12 Abstracts and one Symposium further support potential of ensifentrine,
a…

Sequana Medical announces FDA clearance of IND application for DSR® 2.0 for treatment of congestive heart failure
MOJAVE study on track to start in Q2 2023 as planned, with…

Destiny Pharma and SporeGen® announce update from research collaboration under Innovate UK grant award to develop a biotherapeutic treatment (SPOR-COV®) for COVID-19 and Influenza
Positive results from testing SPOR-COV in several COVID-19 and…

Curve Therapeutics Expands Leadership Team and Scientific Advisory Board
Dr Monika Ermann appointed Vice President Drug Discovery…
We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
Optimum Strategic Communications’ specialist team has an in-depth understanding of how to communicate complex science to investors and corporate stakeholders. Optimum helps life science companies on their journey as they grow and has been trusted by hundreds of healthcare clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York